CBD_STTR_25D_R7.pdf
PDF 157 KB Posted
- Solicitation number
- CBD25D-TP001
About this file
This document is a Proposal Submission Instructions announcement for the Chemical and Biological Defense (CBD) Small Business Technology Transfer (STTR) Program, FY25.D Release 7, managed by the Joint Science and Technology Office for Chemical and Biological Defense (JSTO CBD) at the Defense Threat Reduction Agency (DTRA).
The program seeks innovative technologies to enhance U.S. Military defensive capabilities against chemical and biological warfare threats, with focus areas including detection (point and stand-off), individual and collective protection, decontamination, medical countermeasures, diagnostics, and information systems technology. The announcement includes one open topic: CBD25D-TP001 on Electrochemical Detection of Aerosolized Chem/Biothreats, which seeks development of rapid (<30 seconds), sensitive (<1 µg/m³), and affordable (<$1/sample) portable detection systems using electrochemical methods, AI/ML algorithms, and miniaturized electronics. Phase I funding is capped at $209,575 for up to six months; Phase II proposals may be submitted only after Phase I award and not before five months post-award. All proposals must be submitted through the Defense SBIR/STTR Innovation Portal (DSIP) and include technical volume (maximum 20 pages), cost volume, company commercialization report, and foreign affiliations disclosure. The program requires disclosure of foreign nationals, green card holders, and dual citizens. Research involving human subjects or animal use cannot be proposed in Phase I but may be proposed in Phase II; such research requires separate DoD-level approvals beyond institutional review boards. Selection is based on three evaluation criteria from the DoD STTR Program BAA, with notification of awards within 90 days of BAA closure. The CBD STTR Program does not participate in Direct to Phase II awards or the Technical and Business Assistance (TABA) program for this cycle.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| CBD25D-TP001.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Cleared for Public Release
CBD – 1
CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM
FY25.D Small Business Technology Transfer (STTR)
Release 7
Proposal Submission Instructions
The approved FY25.D topics included in the Chemical and Biological Defense (CBD) Small Business
Technology Transfer (STTR) Program is provided in this document. Offerors responding to this
Announcement must follow all general instructions provided in the Department of Defense (DoD)
Program Announcement, as well as the CBD STTR Topic Instructions provided below, detailing specific CBD STTR program requirements.
Proposers are encouraged to thoroughly review the DoD Program Broad Agency Announcement
(BAA), as well as register for the DoD SBIR/STTR Innovation Portal (DSIP) Listserv to remain apprised of important programmatic and contractual changes.
• The DoD Program BAA: https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations. Be sure to select the tab for the appropriate BAA cycle.
• Register for the DSIP Listserv at: https://www.dodsbirsttr.mil/
Please read the entire DoD BAA and these CBD STTR instructions carefully prior to submitting your proposal. Important programmatic changes have been incorporated as required by the SBIR and STTR
Extension Act of 2022 (Pub. L. 117-183)1. Also, go to https://www.sbir.gov/about/policies to read the
SBIR/STTR Policy Directive issued by the U. S. Small Business Administration (SBA).
INTRODUCTION
In response to Congressional interest in the readiness and effectiveness of U.S. Nuclear, Biological and
Chemical (NBC) warfare defenses, Title XVII of the National Defense Authorization Act for Fiscal
Year 1994 (Public Law 103-160) requires the Department of Defense (DoD) to consolidate management and oversight of the Chemical and Biological Defense Program (CBDP) into a single office – Office of the Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense
Programs. The Joint Science and Technology Office for Chemical and Biological Defense (JSTO
CBD), located at the Defense Threat Reduction Agency (DTRA), provides the management for the
Science and Technology component of the Chemical and Biological Defense Program. Technologies developed under the Small Business Technology Transfer (STTR) Program have the potential to transition to the Joint Program Executive Office for Chemical Biological Radiological and Nuclear
Defense (JPEO CBRND) if the appropriate level of technology maturity is demonstrated. The JSTO
CBD Science & Technology programs and initiatives improve defensive capabilities against Chemical and Biological Weapons of Mass Destruction. The STTR portion of the CBD Program is managed by
JSTO CBD.
The mission of the Chemical and Biological Defense Program is to ensure that the U.S. Military has the capability to operate effectively and decisively in the face of chemical or biological warfare threats at home or abroad. Numerous factors continually influence the program and its technology development priorities. Improved defensive capabilities are essential to mitigate the overall impact of chemical and biological threats. The U.S. military requires the finest state-of-the-art equipment and instrumentation available to permit our Joint Force to ‘detect to warn’ and avoid contamination, if possible – and to be able to sustain operations in a potentially contaminated environment. Further information is available at the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense
Programs homepage at https://www.acq.osd.mil/ncbdp/cbd/
1 The full text of the Extension Act is available at https://www.congress.gov/117/plaws/publ183/PLAW-117publ183.pdf https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations http://www.dodsbirsttr.mil/ https://www.sbir.gov/about/policies https://www.acq.osd.mil/ncbdp/cbd/ http://www.congress.gov/117/plaws/publ183/PLAW-117publ183.pdf
CBD – 2
The overall objective of the CBD STTR Program is to improve the transition or transfer of innovative
Chem-Bio technologies to the end user – the Joint Force – in addition to commercializing technologies within the private sector for mutual benefit. The CBD STTR Program targets those technology efforts that maximize a strong defensive posture in a biological or chemical environment using passive and active means as deterrents. These technologies include chemical and biological detection for both point and stand-off capabilities; individual and collective protection; hazard mitigation (decontamination);
medical pre-treatments (e.g., vaccine development and delivery); medical therapeutics (chemical and biological countermeasures); medical diagnostics; information systems technology to include but not limited to modeling and simulation (e.g., meteorological dispersion), disease surveillance, data fusion, and health & human effects to include wearable technologies.
All proposals submitted to the CBD STTR program must comply to the terms of this Announcement.
CBD STTR reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality, as determined by Technical Evaluation Team and the CBD STTR program office will be funded. CBD STTR reserves the right to withdraw from negotiations at any time prior to contract award. The Government may withdraw from negotiations at any time for any reason to include matters of national security (foreign persons, foreign influence or ownership, or other related issues).
Use of Foreign Nationals (also known as Foreign Persons), Green Card Holders, and Dual Citizens
See the “Foreign Nationals” section of the DoD STTR Program Announcement for the definition of a
Foreign National (also known as Foreign Persons).
It is the responsibility of ALL offerors proposing who use foreign nationals, green-card holders, or dual citizens, to disclose this information regardless of whether the topic is subject to export control restrictions. Offerors MUST identify any foreign nationals or individuals holding dual citizenship expected to be involved on this project as a direct employee, subcontractor, or consultant.
NOTE: For these individuals, specify their country of origin, the type of visa or work permit under which they are performing and an explanation of their anticipated level of involvement on the project.
You may be asked to provide additional information during contract negotiations to verify the foreign citizen’s eligibility to participate on a STTR contract. Supplemental information provided in response to this paragraph will be protected in accordance with the Privacy Act (5 U.S.C. 552a), if applicable, and the Freedom of Information Act (5 U.S.C. 552(b)(6)).
Proposers responding to this BAA must follow all general instructions provided in the Department of
Defense (DoD) STTR Program BAA, paying special attention to the requirements under the SBIR and
STTR Extension Act of 2022 (Pub. L. 117-183). The Chemical and Biological Defense STTR Program requirements are provided in the instructions below.
Specific questions pertaining to the administration of the Chemical and Biological Defense STTR
Program and these proposal preparation instructions should be directed to the Chemical and Biological
Defense SBIR/STTR Program Management Office, JSTO CBD, at dtra.belvoir.rd.mbx.jsto- cbd-chem-bio-defense-sbir@mail.mil.
mailto:dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil
CBD – 3
This release contains an Open Topic. As outlined in Section 7 of the SBIR and STTR Extension Act of
2022, innovation open topic activities—
(A) Increase the transition of commercial technology to the Department of Defense;
(B) Expand the small business nontraditional industrial base;
(C) Increase commercialization derived from investments of the Department of Defense; and
(D) Expand the ability for qualifying small business concerns to propose technology solutions to meet the needs of the Department of Defense.
Unlike conventional topics, which specify the desired technical objective and output, open topics can use generalized mission requirements or specific technology areas to adapt commercial products or solutions to close capability gaps, improve performance, or provide technological advancements in existing capabilities.
A Small Business Concern (SBC) may only submit one (1) proposal to each Open Topic. If more than one proposal from a SBC is received for a single Open Topic, only the most recent proposal to be certified and submitted prior to the submission deadline will receive an evaluation. All prior proposals submitted by the SBC for the same Open Topic will be marked as nonresponsive and will not receive an evaluation.
PHASE I PROPOSAL GUIDELINES
The Defense SBIR/STTR Innovation Portal (DSIP) is the official portal for DoD SBIR/STTR proposal submission. Firms are required to submit proposals via DSIP; proposals submitted by any other means will be disregarded. Detailed instructions regarding registration and proposal submission are provided in the DoD STTR Program BAA.
a. Proposal Coversheet (Volume 1)
The proposal coversheet must follow the instructions and requirements provided in the DoD STTR
Program BAA.
The offeror shall certify that to the best of its knowledge and belief, its eligibility information under the
STTR Program is accurate, complete, and current as of the date of the offer.
b. Technical Volume (Volume 2)
The Technical Volume is not to exceed 20-pages and must follow the formatting requirements provided in the DoD STTR Program BAA. No other information included in the other proposal volumes will count against the Proposal Technical Volume page limit. Pages provided exceeding this length will not be considered for review. The proposal must not contain any font type smaller than 10-point font size
(except as a legend on reduced drawings, but not in the tables).
The maximum dollar amount for a Phase I proof-of-concept/feasibility study is $209,575.00 for a period of performance (PoP) of up to six (6) months. The CBD STTR Program will not accept proposals exceeding this amount for the Phase I effort.
The entire proposal submission must be through the Defense SBIR/STTR Innovation Portal
(DSIP) located at: https://www.dodsbirsttr.mil. Any questions pertaining to the DoD SBIR/STTR submission process and system should be directed to DSIP Support:
DoDSBIRSupport@reisystems.com
Selection of Phase I proposals will be based upon the three (3) evaluation criteria as mentioned in the
DoD BAA. The CBD STTR Program reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality deemed by the Technical Evaluation Team will be https://www.dodsbirsttr.mil/ mailto:DoDSBIRSupport@reisystems.com
CBD – 4
funded. All STTR contract awards, both Phase I and Phase II, are subject to availability of funding.
The brief Period of Performance available for a Phase I project precludes plans that include research involving human or animal subjects as all associated DoD requirements and the necessary approvals must be strictly adhered to and require considerable coordination and significant time for final protocol approvals. See “Research Involving Human Subjects, Biospecimens, and/or Animal Use,” below for further information.
Proposals not conforming to the terms of this Announcement, and any unsolicited proposals, will not be considered. All awards are subject to the availability of funding and successful completion of contract negotiations. The Chemical and Biological Defense Program is not responsible for any funds expended by the proposer prior to contract award.
c. Cost Volume (Volume 3)
The Cost Volume must follow all instructions and requirements provided in the DoD STTR Program
BAA. The Phase I Base amount must not exceed $209,575.00. Total Base cost for Phase I must be clearly identified on the Proposal Cover Sheet (Volume 1) and in Volume 3.
d. Company Commercialization Report (CCR) (Volume 4)
Completion of the CCR is required and included in Volume 4 of the DSIP portal. Please refer to the
DoD STTR Program BAA for full details on this requirement. Information contained in the CCR will not be considered by the Chemical and Biological Defense Program in the proposal evaluations.
e. Supporting Documents (Volume 5)
Volume 5 is provided for proposing SBCs to submit additional documentation to support the Coversheet
(Volume 1), Technical Volume (Volume 2), and the Cost Volume (Volume 3). Please refer to the DoD
Program BAA for more information. Offerors are welcome to provide Supporting Documents in this section, however these documents will not be considered by the Chemical and Biological Defense
Program in the proposal evaluations.
f. Fraud, Waste and Abuse (Volume 6)
All offerors must complete the Fraud, Waste, and Abuse training through the DSIP portal
(https://www.dodsbirsttr.mil). Please follow the guidance provided via DSIP to complete the required training prior to proposal submission.
To Report Fraud, Waste, or Abuse, please contact:
DoD Inspector General (IG) Fraud, Waste & Abuse
Hotline: (800) 424-9098 hotline@dodig.mil
Additional information on Fraud, Waste and Abuse may be found in the DoD Announcement.
g. Disclosures of Foreign Affiliations or Relationships to Foreign Countries (Volume 7)
SBCs must complete the Disclosures of Foreign Affiliations or Relationships to Foreign Countries webform in Volume 7 of the DSIP proposal submission. Please be aware that the Disclosures of Foreign
Affiliations or Relationships to Foreign Countries WILL NOT be accepted as a PDF Supporting
Document in Volume 5 of the DSIP proposal submission. Do not upload any previous versions of this form to Volume 5. For additional details, please refer to the DoD Program BAA.
DIRECT TO PHASE II PROPOSAL GUIDELINES
mailto:hotline@dodig.mil
CBD – 5
The Chemical and Biological Defense STTR Program is not participating in Direct to Phase II topics during this BAA cycle.
PHASE II PROPOSAL GUIDELINES
Offerors may only submit a Phase II proposal after receipt of a Phase I award.
Phase II is the demonstration of the technology that was found feasible in Phase I. A Phase II proposal may not be submitted until sufficient Phase I progress can be evaluated and assessed, and the PoP is nearing completion. The SBC may not submit a Phase II proposal sooner than five (5) months from the date of the Phase I contract award, and upon receiving instructions from the CBD program office.
All Phase II proposal submissions must be submitted on the DSIP portal: https://www.dodsbirsttr.mil.
At the DSIP website, Phase II proposals MUST be submitted to ‘CBD STTR’ regardless of which DoD contracting office negotiated and awarded the Phase I contract. Additional instructions regarding the
Phase II proposal submission process including submission dates will be provided to Phase I awardees after the Phase I contract is awarded.
The Phase II proposal must include a concise summary of the Phase I project including the specific technical problem or opportunity addressed in the proposal. The proposal must also include an objective statement, the type of research conducted, findings and/or results of the research, and technical feasibility of the technology. Due to limited funding, the CBD STTR program reserves the right to limit awards under any topic and only proposals considered to be of superior quality will be funded.
All proposers are required to submit a commercialization plan that describes the SBC’s marketing and manufacturing approach to developing the technology. The Offeror is required to submit a budget for the entire 24-month, Phase II Period of Performance. During contract negotiation, the Contracting
Officer may require a Cost Volume for a base year and an option year; thus, proposers are advised to be aware of this possibility. These costs must be submitted using the Cost Volume format within the DSIP portal. The total proposed amount should be indicated on the Proposal Cover Sheet as the Proposed
Cost. At the Contracting Officer’s discretion, Phase II projects may be evaluated for technical progress prior to the end of the base year (year one), to decide whether to extend the funding for the option year
(year two).
The CBD STTR Program is committed to minimizing the funding gap between Phase I and Phase II activities. The CBD STTR Program typically funds a cost-plus fixed fee Phase II award at the discretion of the Contracting Officer but may award a firm fixed price contract.
It is recommended that Phase II awardees have a Defense Contract Audit Agency (DCAA) approved accounting system. If you do not have a DCAA approved accounting system, this could delay/prevent a
Phase II contract award. Visit https://www.dcaa.mil/Customers/Small-Business for more information on
DCAA approved accounting systems.
DISCRETIONARY TECHNICAL AND BUSINESS ASSISTANCE (TABA)
Currently, the CBD STTR Program does not participate in the Technical and Business Assistance
(TABA) Program.
EVALUATION AND SELECTION
All proposals will be evaluated in accordance with the evaluation criteria listed in the DoD STTR
Program BAA.
https://www.dcaa.mil/Customers/Small-Business
CBD – 6
Offerors will be notified of selection or non-selection within the 90-day window requirement at the close of the BAA. The CBD STTR Program office will notify the firm via e-mail to the firm’s
Corporate Official (Business Point of Contact) and Principal Investigator, as listed on the Cover Page of the proposal.
The firm may submit an email request to the CBD SBIR/STTR inbox (https://dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil) to request a technical debrief. The CBD STTR Program Office will send a debriefing statement to the firm. The debriefing statement will only be provided to the
Corporate Official and the Principal Investigator on the Cover Page of the proposal. Requests made by the offeror for further information will not be provided.
Refer to the DoD STTR Program BAA for guidance concerning protests.
As further prescribed in FAR 33.106(b), FAR 52.233-3, Protests after Award should be submitted to the Chemical and Biological Defense (CBD) SBIR/STTR Program Management Office for the Joint
Science and Technology Office for Chemical and Biological Defense (JSTO CBD), dtra.belvoir.rd.mbx.jsto-cbd- chem-bio-defense-sbir@mail.mil.
RESEARCH INVOLVING HUMAN SUBJECTS, BIOSPECIMENS, AND/OR ANIMAL USE
Any research under a Phase I or Phase II contract involving human subjects, human anatomical substances (e.g., whole blood, cell lines, tissue), and/or animal use must undergo the regulatory review requirements per DoD Instruction 3216.02 and DoD Instruction 3216.01, respectively.
A DoD-level review and approval of human and/or animal use are separate from, and in conjunction with the Institutional Review Board (IRB) and/or the Institutional Animal Care and Use Committee
(IACUC).
CBD STTR Projects Requiring Animal Subjects
Refer to the DoD Program BAA for Research Involving Animal Subjects.
Companies should plan carefully for any research involving animal subjects, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of Concern (DURC)”. The mandatory DoD level review of this research is typically a period of no greater than four (4) months.
Projects under CBD STTR awards involving the use of animal subjects shall not be proposed for any
Phase I Period of Performance but may be proposed during the Phase II proposal submission.
Written authorization to begin animal research under the applicable protocol(s) proposed as part of the
CBD SBIR/STTR program will be issued after the contract award in the form of an approval memo from the U.S. Army Medical Research and Development Command (MRDC), Animal Care and Use
Review Office (ACURO), and the Research Oversight Board (ROB) of the Defense Threat Reduction
Agency (DTRA), both of which provide DoD compliance oversight to the CBD SBIR and STTR program office.
NOTE: The offeror is expressly forbidden from using or subcontracting for the use of animals in any manner prior to these approvals. Furthermore, modifications to approved protocols require review and approval by the ACURO prior to implementation.
mailto:cbd-chem-bio-defense-sbir@mail.mil
CBD – 7
Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The ACURO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Animal Care and Use Committee (IACUC) review(s). Further information may be required if the proposal is successful.
CBD STTR Projects Requiring Human Subjects, Human Anatomical Substances, and/or Human Data
Refer to the DoD Program BAA for Research Involving Human Subjects and Recombinant DNA
Molecules.
Companies should plan carefully for any research involving human subjects, human data, and/or human biospecimens (e.g., blood, saliva, tissue), to include cadaveric specimens, hereafter referred to as
“human subjects”, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of Concern (DURC)”. The mandatory DoD level review of this research is typically no greater than four (4) months.
Projects under CBD STTR awards involving the use of human subjects shall not be proposed for any
Phase I Period of Performance but may be proposed during the Phase II proposal submission.
Written authorization to begin the research under the applicable protocol(s) proposed as part of the CBD
SBIR/STTR program will be issued after the contract award in the form of an approval memo from the
U.S. Army Medical Research and Development Command (MRDC), Office of Human Research
Oversight (OHRO), and the Research Oversight Board (ROB) of the Defense Threat Reduction Agency
(DTRA), both of which provide DoD compliance oversight to the CBD SBIR and STTR program office.
NOTE: The offeror is expressly forbidden from beginning the research in any manner prior to these approvals. Furthermore, modifications to approved protocols require review and approval by the OHRO prior to implementation.
Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The OHRO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Review Board (IRB) review(s). Further information may be required if the proposal is successful.
CBD – 8
CBD STTR 25.D Release 7
Topic Index
CBD25D-TP001 Electrochemical Detection of Aerosolized Chem/Biothreats – Open Topic
CBD – 9
CBD25D-TP001 Electrochemical Detection of Aerosolized Chem/Biothreats – Open Topic
OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Biotechnology, Trusted AI and Autonomy, Advanced Materials
OBJECTIVE: This STTR Open Topic seeks to develop and integrate innovative electrochemical detection methodologies, AI/ML-driven signal analysis algorithms, and portable electronic platforms capable of rapid, sensitive, and specific detection of aerosolized chem/biothreat species.
DESCRIPTION: Solid or liquid aerosols containing virus particles, anthrax, fentanyl, or other biothreats may be weaponized (e.g., Moscow Dubrovka Hostage Situation[1]) and pose significant risk to the DoD mission domestically and abroad, threatening Force readiness, installation security, and border security where Soldiers may be deployed.
Current detection methods are often limited by size, cost complexity, and slow response times. For example, laboratory-based analyses are highly accurate but impractical for immediate field use. Existing portable devices (colorimetric strips, ELISA, light scattering) may suffer from interference, leading to false positives or negatives. These portable methods also generally require 3-10 minutes to make a positive detection. Most notably, the analytical sensitivity must be extremely high to detect the presence of aerosols before the threat level exceeds survivability metrics. Thus, there is a critical need for innovative technologies that offer selective (analyte/interferant differentiation), rapid (<30 s), sensitive
(<1 µg/m3), and affordable (<$1/sample) detection with a portable formfactor for ease of use for
Soldiers. [2]
Electrochemical methods can achieve high sensitivity and selectivity, rapid response times, and are amenable to miniaturization; however, despite significant academic research, a viable platform has yet to be commercialized for these applications. Recently, exciting developments have been reported for single-entity virus and bacterial measurements [3], nanomaterial sorbents [4], electrochemical AI development [5], and instrumental miniaturization [6]. Thus, by researching microenvironment manipulation techniques, incorporating advanced transducer materials, leveraging AI/ML-driven signal analyses, and/or integrating miniaturized electronic platforms, in-field detection of aerosolized biothreats may be possible to enhance Force protection and tactical awareness.
This STTR Open Topic seeks to (1) uncover innovative electrochemical sensing methodologies to overcome the limitations described above, and (2) pair those methodologies with emerging portable electronic platforms and/or AI/ML data analysis algorithms. The focus is on creating portable, reusable devices that provide real-time results with minimal false readings, driven by innovative chemistry or algorithms to quickly provide Soldiers tactical information. This technology would enhance the DoD capabilities for counter-terrorism operations, security screening, and operational awareness. The development also holds significant potential for dual-use applications in law enforcement, homeland security, and public health sectors, representing an important enabler to combat the future pandemics, the opioid crisis, and to protect Soldiers from chem/bioweapons leveraging these compounds. PHASE I:
Demonstrate the feasibility of innovative electrochemical detection methods for relevant chem/biothreat
(or analog) aerosols. Conduct laboratory experiments and/or modeling analysis to develop and validate the proposed sensing techniques in solid and/or liquid aerosol media while assessing:
• Sensitivity using limit of detection (LOD) and limit of quantitation (LOQ) in µg/m3
• Selectivity for a target analyte against common interferants or blank aerosols using signal ratio approaches and false positive/negative analyses
CBD – 10
• Reproducibility using coefficient of variation (CV) analyses
Also of interest is leveraging empirical or synthetic data to train AI/ML algorithms capable of deconvoluting complex signals related to these metrics. The desired outcome is a proof-of-concept demonstration showing reliable electrochemical detection of aerosol contents in controlled settings, establishing a foundation for component integration and development in Phase II.
PHASE II: Develop and refine a minimally viable integrated component system of the electrochemical detection methodology, the miniaturized electronic platform, and/or the AI/ML-driven signal analysis based on successful Phase I results. The minimally viable system should:
• Achieve high sensitivity (<1 µg/m3) for solid or liquid aerosolized biothreats
• Demonstrate selectivity for target analytes where interferants or blanks represent <10% of the analytical signal and result in >95% accuracy for positive/negative readings at environmentally relevant aerosol concentrations
• Achieve coefficients of variation (CV) <10% for equivalent trials
• Provide rapid detection results in <30 seconds
• Directly integrate sensing methods, electronics, and algorithms with mobile platforms (phone, pad, etc.) with minimal size, weight, power, and cost (SWaP-C)
The component system should undergo extensive testing in simulated field conditions to validate performance. User testing should also be performed with relevant DoD research Centers or partners to generate a feedback cycle for device improvement. The outcome is a minimally viable component system (TRL 5) with directives for prototype assembly and evaluation in Phase III.
PHASE III: Transition the technology for Department of Defense applications, focusing on full-scale production, certification, and integration into military analysis toolkits. Specific tasks include refining the prototype based on field testing feedback, ensuring compliance with regulatory standards, developing scalable manufacturing processes, and establishing training programs/GUIs for DoD end-users.
Commercialization opportunities in civilian markets should also be pursued by adapting the technology for law enforcement, border protection, and public health sectors.
PHASE III DUAL USE APPLICATIONS: Beyond DoD applications, the device could be utilized by the medical professionals for pandemic response, law enforcement for roadside testing and investigations, or customs agencies for border security, enhancing public safety and health responses.
REFERENCES:
1. Wax, P. M.; Becker, C. E.; Curry, S. C. Unexpected “Gas” Casualties in Moscow: A Medical
Toxicology Perspective. Annals of Emergency Medicine 2003, 41 (5), 700–705.
https://doi.org/10.1067/mem.2003.148.
2. Glasscott, M. W.; Vannoy, K. J.; Iresh Fernando, P. U. A.; Kosgei, G. K.; Moores, L. C.; Dick, J. E.
Electrochemical Sensors for the Detection of Fentanyl and Its Analogs: Foundations and Recent
CBD – 11
Advances. TrAC Trends in Analytical Chemistry 2020, 132, 116037.
https://doi.org/10.1016/j.trac.2020.116037.
3. Manring, N.; Ahmed, M. M. N.; Tenhoff, N.; Smeltz, J. L.; Pathirathna, P. Recent Advances in
Electrochemical Tools for Virus Detection. Analytical Chemistry 2022, 94 (20), 7149–7157.
https://doi.org/10.1021/acs.analchem.1c05358.
4. Shao, W.; Zeng, Z.; Star, A. An Ultrasensitive Norfentanyl Sensor Based on a Carbon Nanotube-
Based Field-Effect Transistor for the Detection of Fentanyl Exposure. ACS Applied Materials &
Interfaces 2023, 15 (31), 37784–37793. https://doi.org/10.1021/acsami.3c05958.
5. Shao, W.; Sorescu, D. C.; Liu, Z.; Star, A. Machine Learning Discrimination and Ultrasensitive
Detection of Fentanyl Using Gold Nanoparticle‐Decorated Carbon Nanotube‐Based Field‐Effect
Transistor Sensors. Small 2024, 20 (2311835). https://doi.org/10.1002/smll.202311835.
6. Brown, E. W.; Glasscott, M. W.; Conley, K.; Barr, J.; Ray, J. D.; Moores, L. C.; Netchaev, A.
ACEstat: A DIY Guide to Unlocking the Potential of Integrated Circuit Potentiostats for Open-Source
Electrochemical Analysis. Analytical Chemistry 2022, 94 (12), 4906–4912.
https://doi.org/10.1021/acs.analchem.1c04226.
KEYWORDS: Electrochemical, Sensor, Biothreat, Virus, Bacterial, Opioids, Portable, AI/ML
File details come from the government source that posted it. Updated .